SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193805-21-000538
Filing Date
2021-04-26
Accepted
2021-04-26 17:15:26
Documents
13
Period of Report
2021-04-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 e620514_8k-arct.htm   iXBRL 8-K 25579
2 e620514_ex10-1.htm EX-10.1 52287
  Complete submission text file 0001193805-21-000538.txt   264557

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA arct-20210421.xsd EX-101.SCH 3029
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE arct-20210421_lab.xml EX-101.LAB 34238
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arct-20210421_pre.xml EX-101.PRE 22361
6 EXTRACTED XBRL INSTANCE DOCUMENT e620514_8k-arct_htm.xml XML 3626
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38942 | Film No.: 21854943
SIC: 2834 Pharmaceutical Preparations